Evidence map›Paper›PMID 39417319›Full record

ArticleJournal of the American Chemical Society2024

Enzyme-Sialylation-Controlled Chemical Sulfation of Glycan Epitopes for Decoding the Binding of Siglec Ligands.

Shengzhou Ma, Pengfei Zhang, Jinfeng Ye, Yinping Tian, Xiao Tian, Jaesoo Jung, Matthew S Macauley, Jiabin Zhang, Peng Wu, Liuqing Wen

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Defining substrate specificities ofOrganic chemistry frontiers : an international journal of organic chemistry · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shengzhou MaCarbohydrate-Based Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Pengfei ZhangCarbohydrate-Based Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Jinfeng YeDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, California 92037, United States.
Yinping TianCarbohydrate-Based Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.ORCID 0000-0002-6998-0612
Xiao TianZhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, Guangdong 528400, China.
Jaesoo JungDepartment of Chemistry, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.
Matthew S MacauleyDepartment of Chemistry, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.ORCID 0000-0003-4579-1048
Jiabin ZhangCarbohydrate-Based Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.ORCID 0000-0003-0128-655X
Peng WuDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, California 92037, United States.ORCID 0000-0002-5204-0229
Liuqing WenCarbohydrate-Based Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.ORCID 0000-0001-9187-7999

Funding

Exploring Siglec-glycan ligand interactions using chemoenzymatic approachesR01AI154138 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI WU, PENG · 2021 to 2025
$4.1M
NIAID NIH HHS R01 AI154138
6 · The paper itself

Abstract

Widely distributed in nature, sulfated glycan epitopes play important roles in diverse pathophysiological processes. However, due to their structural complexity, the preparation of glycan epitopes with structurally defined sulfation patterns is challenging, which significantly hampers the detailed elucidation of their biological functions at the molecular level. Here, we introduce a strategy for site-specific chemical sulfation of glycan epitopes, leveraging enzymatic sialylation and desialylation processes to precisely control the regio-specificity of sulfation of disaccharide or trisaccharide glycan backbones. Using this method, a sulfated glycan library covering the most common sialylated glycan epitopes was prepared in high yield and efficiency. By screening a microarray prepared with this glycan library, we systematically probed their binding specificity with human Siglecs (sialic acid-binding immunoglobulin-type lectins), many of which function as glyco-immune checkpoints to suppress immune system activation. Our investigation revealed that sulfation and sialylation patterns serve as important determinants of Siglec binding affinity and specificity. Thus, these findings offer new insights for the development of research tools and potential therapeutic agents targeting glyco-immune checkpoints by modulating the Siglec signaling pathway.

Indexed as

EpitopesPolysaccharidesSialic Acid Binding Immunoglobulin-like LectinsHumansLigandsProtein BindingSulfatesEpitopesLigandsPolysaccharidesSialic Acid Binding Immunoglobulin-like LectinsSulfates

Identifiers

PMID39417319
PMCPMC11673104

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.